FindTrial
Sign In

Impact of vitamin D on gut microbiome and complications in patients with diabetes

The Impact of Vitamin D Supplementation on Diabetic Complications and Gut Microbiome Diversity in Type 2 Diabetes Mellitus - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/08/056899
Enrollment
300
Registered
2023-08-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Nil: Not applicable

Sponsors

Manipal Academy of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: T2DM patients who are prescribed with the vitamin D supplementation

Exclusion criteria

Exclusion criteria: Patients who are pregnant or lactating, patients suffering from type 1 diabetes, any malignancies, HIV infections, kidney diseases other that diabetic kidney disease, and patients who are on vitamin D supplements or immunosuppressants, or drugs that can alter vitamin D levels

Design outcomes

Primary

MeasureTime frame
The cost-effectiveness of various dosing regimens of vitamin D in T2DM will be understoodTimepoint: 6 & 12 months—

Secondary

MeasureTime frame
The association of vitamin D supplementation with gut microbiome levels & diabetic complications will be understoodTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr Leelavathi D Acharya

Manipal College of Pharmaceutical Sciences

leela.da@manipal.edu9448159927

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026